1. Home
  2. LMND vs BLCO Comparison

LMND vs BLCO Comparison

Compare LMND & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$67.48

Market Cap

5.4B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.93

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
BLCO
Founded
2015
1853
Country
United States
Canada
Employees
1282
N/A
Industry
Property-Casualty Insurers
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.4B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
LMND
BLCO
Price
$67.48
$15.93
Analyst Decision
Buy
Buy
Analyst Count
7
11
Target Price
$70.86
$18.45
AVG Volume (30 Days)
1.4M
340.4K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$65.20
$8.65
Revenue Next Year
$33.31
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.47
52 Week Low
$35.70
$13.09
52 Week High
$99.90
$18.92

Technical Indicators

Market Signals
Indicator
LMND
BLCO
Relative Strength Index (RSI) 54.31 47.04
Support Level $50.45 $15.36
Resistance Level $72.31 $16.54
Average True Range (ATR) 4.28 0.49
MACD -0.69 -0.06
Stochastic Oscillator 29.24 6.21

Price Performance

Historical Comparison
LMND
BLCO

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: